Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach
Journal of Pharmaceutical Innovation · 2026-08 · 21 (4)
DOI: 10.1007/s12247-026-10582-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 19.03.2026. Verfasst von Bhargav Chandegra und 3 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chandegra, B., Suthar, R., Raval, J., & Prajapati, P. (2026). Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach. Journal of Pharmaceutical Innovation, 21(4). https://doi.org/10.1007/s12247-026-10582-2
Vancouver
Chandegra B, Suthar R, Raval J, Prajapati P. Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach. Journal of Pharmaceutical Innovation. 2026;21(4). doi:10.1007/s12247-026-10582-2
BibTeX
@article{Chandegra2026,
author = {Chandegra, Bhargav and Suthar, Rajnikant and Raval, Jigar and Prajapati, Prajesh},
title = {Formulation and Optimization of Novel Liposomal Formulation of Quetiapine Fumarate Intranasal Drug Delivery Using Box Behnken Design Approach},
journal = {Journal of Pharmaceutical Innovation},
year = {2026},
volume = {21},
number = {4},
doi = {10.1007/s12247-026-10582-2}
}
EUVIMED